This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Kaohsiung Medical University. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: A-Mei Huang: Innovator in Pharmaceutical Composition
Introduction
A-Mei Huang is a distinguished inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anticancer and anti-inflammatory properties. With a total of 3 patents, Huang's work is paving the way for innovative treatments in medicine.
Latest Patents
Huang's latest patents include a focus on ursolic acid derivatives and their pharmaceutical compositions. These derivatives are designed to exhibit anticancer and anti-inflammatory effects. One of his notable inventions is a method for increasing reactive oxygen species in cells, which involves administering a pharmaceutical composition containing an ursolic acid derivative. Additionally, he has developed a derivative of 18β-glycyrrhetinic acid that is effective in suppressing cancer cells. This invention includes various structural components that enhance its efficacy against cancer.
Career Highlights
A-Mei Huang is affiliated with Kaohsiung Medical University, where he conducts research and develops innovative pharmaceutical solutions. His work is characterized by a commitment to advancing medical science and improving patient outcomes through effective drug formulations.
Collaborations
Huang collaborates with esteemed colleagues such as Tzyh-Chyuan Hour and Shyh-Chyun Yang. Their combined expertise contributes to the success of their research initiatives and the development of groundbreaking pharmaceutical compositions.
Conclusion
A-Mei Huang's contributions to the field of pharmaceuticals are noteworthy, particularly in the area of cancer treatment. His innovative patents and collaborations reflect a dedication to improving healthcare through scientific advancements.